NovaBridge Biosciences (NBP) — Net Asset Quality Index
NovaBridge Biosciences (NBP) has a Net Asset Quality Index of 93.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.97 Billion minus total liabilities of $131.67 Million yields net assets of $1.84 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read NBP current and long-term liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
NovaBridge Biosciences Net Asset Quality Index Over Time (2017–2024)
This chart shows how NovaBridge Biosciences's Net Asset Quality Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at 93.3%, representing net assets of $1.84 Billion against total assets of $1.97 Billion USD. For live market cap and overall valuation, see market cap of NovaBridge Biosciences.
Annual Net Asset Quality Index for NovaBridge Biosciences (2017–2024)
The table below presents the year-by-year Net Asset Quality Index for NovaBridge Biosciences from 2017 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check NBP strategic asset allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 94.6% | $201.16 Million | $212.68 Million | $11.52 Million | ▲ +28.8 pp |
| 2023 | 65.8% | $1.72 Billion | $2.61 Billion | $894.81 Million | ▼ -8.1 pp |
| 2022 | 73.8% | $3.01 Billion | $4.07 Billion | $1.07 Billion | ▼ -7.6 pp |
| 2021 | 81.5% | $4.59 Billion | $5.63 Billion | $1.04 Billion | ▼ -7.3 pp |
| 2020 | 88.8% | $5.63 Billion | $6.33 Billion | $706.65 Million | ▲ +205.9 pp |
| 2019 | -117.1% | $-2.03 Billion | $1.74 Billion | $3.77 Billion | ▼ -76.9 pp |
| 2018 | -40.2% | $-955.10 Million | $2.38 Billion | $3.33 Billion | ▼ -11.0 pp |
| 2017 | -29.2% | $-299.80 Million | $1.03 Billion | $1.33 Billion | — |